Insights

3 buy-rated ASX shares

Here are three quality ASX shares rated as buys…
The post 3 buy-rated ASX shares appeared first on The Motley Fool Australia. –

With so many shares to choose from on the Australian share market, it can be hard to decide which ones to buy over others.

To narrow things down, I have picked out three options that are highly rated to consider:

Domino’s Pizza Enterprises Ltd (ASX: DMP)

The first ASX share to consider this month is this pizza chain giant. It has been tipped to continue its strong growth over the next decade thanks to its bold expansion plans at home and overseas, acquisitions, and its focus on technology. And while food inflation is likely to weigh on its performance in the near term, this is only expected to be temporary. Which could mean the recent weakness in the Domino’s share price is a buying opportunity for long-term focused investors.

Goldman Sachs is positive on Domino’s. It currently has a buy rating and $147.00 price target on the pizza chain operator’s shares.

Hipages Group Holdings Ltd (ASX: HPG)

Another ASX share to look at is Hipages. It is a leading Australian-based online platform and software as a service (SaaS) provider connecting consumers with over 30,000 trusted tradies. Hipages has been growing at a rapid rate over the last couple of years and looks well-placed to continue this strong form as it builds out its ecosystem. This will be supported by the recent acquisition of New Zealand rival Builderscrack, which gives Hipages access to a NZ$26 billion total addressable market and 4,000 active tradies.

Goldman Sachs is very bullish on Hipages. It currently has a buy rating and $5.15 price target on its shares.

ResMed Inc. (ASX: RMD)

A final ASX share to look at is ResMed. It is a medical device company with a focus on the sleep treatment market. ResMed has been a very strong performer over the last decade, generating mouth-watering returns for investors. The good news is that the next decade looks positive. This is thanks to its world class products, significant market opportunity, and the growing prevalence of sleep disorders. Its near term performance is also being boosted by a major product recall (5.2m CPAP devices) from Philips.

Morgans is positive on the company and has an add rating and $40.80 price target on ResMed’s shares.

The post 3 buy-rated ASX shares appeared first on The Motley Fool Australia.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.

*Returns as of January 12th 2022

More reading

Here are the top 10 ASX shares today

Why AnteoTech, BrainChip, City Chic, and ResMed shares are charging higher

Analysts name 2 excellent ASX growth shares to buy right now

Why Domino’s, Fortescue, Medibank, and Metcash shares are falling

ASX 200 (ASX:XJO) midday update: Afterpay-Block deal approved, Fortescue downgraded

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns and has recommended Hipages Group Holdings Ltd. The Motley Fool Australia has recommended Dominos Pizza Enterprises Limited, Hipages Group Holdings Ltd., and ResMed Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;


To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.


An active and funded account with a positive trading balance is required to continue to have access to the tools;


Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;


Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!